INMB Inmune Bio Inc.

Fundamentals / CIK 0001711754 / USD

Inmune Bio Inc. reported $50K in revenue and a net loss of $16.67M for the fiscal year ended December 31, 2025 (up 257.1% year over year), with a -35542.0% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open INMB in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

9 fiscal years (2017 to 2025), reported in USD.

$5.22M$2.61M$0-$42.98MFY 2017 Revenue: $0FY 2017 Net Income: -$831K2017FY 2018 Revenue: $0FY 2018 Net Income: -$12.44M2018FY 2019 Net Income: -$7.68M2019FY 2020 Revenue: $11KFY 2020 Net Income: -$12.10M2020FY 2021 Revenue: $181KFY 2021 Net Income: -$30.34M2021FY 2022 Revenue: $374KFY 2022 Net Income: -$27.30M2022FY 2023 Revenue: $155KFY 2023 Net Income: -$30.01M2023FY 2024 Revenue: $14KFY 2024 Net Income: -$42.08M2024FY 2025 Revenue: $50KFY 2025 Net Income: -$45.93M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $50K $14K $155K $374K $181K $11K -- $0 $0
Research & Development $20.66M $33.17M $20.27M $17.07M $20.54M $5.92M $3.28M $3.35M $435K
Total Operating Expenses $47.43M $42.65M $29.90M $26.32M $29.33M $12.24M $7.76M $12.44M $981K
Operating Income -$47.38M -$42.63M -$29.74M -$25.95M -$29.15M -$12.23M -$7.76M -$12.44M -$981K
EBITDA -$47.30M -- -- -- -- -- -- -- --
Interest Income -- -- -- -- -- -- $78K -- --
Interest Expense $0 $357K $2.28M $2.01M $985K -- -- -- --
Income Before Tax $45.93M $42.08M $30.01M -- -- -- -- -- --
Income Tax Expense -- -- -- -- -- -- -- $0 $0
Net Income -$45.93M -$42.08M -$30.01M -$27.30M -$30.34M -$12.10M -$7.68M -$12.44M -$831K
Basic EPS -$1.86 -$2.11 -$1.67 -$1.52 -$1.88 -$1.01 -$0.75 -$1.43 -$0.13
Diluted EPS -$1.86 -$2.11 -$1.67 -$1.52 -$1.88 -$1.01 -$0.75 -$1.43 -$0.13
Basic Shares Outstanding 24.8M 19.9M 18.0M 17.9M 16.1M 12.0M 10.3M 8.7M 6.6M
Diluted Shares Outstanding 24.8M 19.9M 18.0M 17.9M 16.1M 12.0M 10.3M 8.7M 6.6M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue -- -- -- $0 $0 $0 $50K $0
Research & Development -- -- $3.64M $2.33M $4.89M $5.80M $7.64M $7.35M
Total Operating Expenses $5.01M $1.48M $5.81M $5.47M $7.43M $24.57M $9.96M $9.47M
Operating Income -$5.01M -$1.48M -$5.81M -$5.47M -$7.43M -$24.57M -$9.90M -$9.47M
EBITDA -$4.91M -$1.38M -$5.76M -- -- -- -- --
Interest Expense -- -- -- -- -- $250K $0 -$395K
Net Income -$4.72M -$1.27M -$5.41M -$5.26M -$6.47M -$24.46M -$9.74M -$9.22M
Basic EPS -$0.17 -$0.05 -$0.20 -- -$0.24 -$1.05 -$0.43 --
Diluted EPS -$0.17 -$0.05 -$0.20 -- -$0.24 -$1.05 -$0.43 --
Basic Shares Outstanding 27.8M 26.7M 26.6M -- 26.6M 23.3M 22.5M --
Diluted Shares Outstanding 27.8M 26.7M 26.6M -- 26.6M 23.3M 22.5M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $24.75M $20.92M $35.85M $52.15M $74.81M $21.97M $7.00M $186K $1.37M
Cash & Short-Term Investments $24.75M $20.92M $35.85M $52.15M $74.81M $21.97M $7.00M $186K $1.37M
Accounts Receivable, Net $4.28M $1.18M $1.91M -- -- -- -- -- --
Total Current Assets $29.89M $22.66M $39.94M $64.67M $82.61M $23.99M $7.76M $849K $1.90M
Property, Plant & Equipment, Net $955K -- -- -- -- -- -- -- --
Intangible Assets -- $16.51M $16.51M $16.51M $16.51M $16.51M $16.51M $16.51M $16.51M
Other Non-Current Assets $595K $79K $131K $99K $99K -- -- -- --
Total Non-Current Assets $2.46M $16.90M $17.06M $17.12M $17.34M $16.67M $16.71M $16.51M $16.51M
Total Assets $32.35M $39.56M $57.00M $81.80M $99.94M $40.66M $24.47M $17.36M $18.41M
Short-Term Debt -- -- $9.92M $5.00M -- -- -- -- --
Other Current Liabilities -- $517K $489K $616K $474K $190K -- -- --
Total Current Liabilities $8.42M $7.22M $18.46M $10.92M $4.36M $1.78M $700K $824K --
Long-Term Debt -- $15.00M -- $9.70M $15.00M -- -- -- --
Total Non-Current Liabilities $411K $244K $397K $10.77M $15.36M $126K $160K $0 --
Total Liabilities $8.83M $7.46M $18.86M $21.69M $19.72M $1.90M $861K $824K $310K
Total Debt (incl. Leases) $1.03M $15.38M $10.44M $15.31M $15.42M $168K $168K -- --
Common Stock $27K $22K $18K $18K $18K $13K $11K $8.7K $8.3K
Retained Earnings -$209.0M -$163.1M -$121.0M -$91.01M -$63.72M -$33.38M -$21.28M -$13.60M -$1.16M
Accumulated Other Comp. Income -$737K -$575K -$799K -$699K $1.0K $11K -$8.5K $6.5K $32K
Total Stockholders' Equity $23.52M $32.10M $37.34M $60.10M $80.22M $38.75M $23.61M $16.54M $18.10M
Total Equity $23.52M $32.10M $37.34M $60.10M $80.22M $38.75M $23.61M $16.54M $18.10M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents -- -- -- $24.75M $27.73M $33.37M $19.34M $20.92M
Cash & Short-Term Investments -- -- -- $24.75M $27.73M $33.37M $19.34M $20.92M
Accounts Receivable, Net $1.21M $4.41M $479K $4.28M $1.70M $1.60M $1.28M $1.18M
Total Current Assets $18.71M $23.80M $22.82M $29.89M $30.67M $36.03M $20.96M $22.66M
Property, Plant & Equipment, Net $1.19M $1.26M $903K $955K $878K $706K -- --
Intangible Assets -- -- -- -- -- -- $16.51M $16.51M
Other Non-Current Assets $531K $537K $683K $595K $746K $570K $49K $79K
Total Non-Current Assets $2.80M $3.05M $3.00M $2.46M $2.69M $1.65M $16.84M $16.90M
Total Assets $21.51M $26.84M $25.82M $32.35M $33.36M $37.68M $37.80M $39.56M
Other Current Liabilities -- -- -- -- -- $511K $480K $517K
Total Current Liabilities $2.92M $5.89M $5.39M $8.42M $7.36M $8.59M $7.93M $7.22M
Long-Term Debt -- -- -- -- -- $15.00M $15.00M $15.00M
Total Non-Current Liabilities $518K $593K $806K $411K $623K $231K $201K $244K
Total Liabilities $3.44M $6.48M $6.19M $8.83M $7.98M $8.82M $8.13M $7.46M
Total Debt (incl. Leases) $1.21M $1.41M $1.51M $1.03M $1.08M $15.45M $15.35M $15.38M
Common Stock $28K $28K $27K $27K $27K $27K $23K $22K
Retained Earnings -$220.4M -$215.7M -$214.4M -$209.0M -$203.8M -$197.3M -$172.8M -$163.1M
Accumulated Other Comp. Income -$840K -$823K -$727K -$737K -$764K -$763K -$610K -$575K
Total Stockholders' Equity $18.07M $20.36M $19.62M $23.52M $25.38M $28.87M $29.67M $32.10M
Total Equity $18.07M $20.36M $19.62M $23.52M $25.38M $28.87M $29.67M $32.10M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$45.93M -$42.08M -$30.01M -$27.30M -$30.34M -$12.10M -$7.68M -$12.44M -$831K
Depreciation & Amortization $84K -- -- -- -- -- -- -- --
Stock-Based Compensation $9.91M $7.61M $7.37M $7.15M $4.80M $3.11M $4.10M $10.00M $200K
Change in Receivables -$3.10M $724K $6.19M -- -- -- -- -- --
Operating Cash Flow -$22.58M -$33.36M -$11.98M -$22.69M -$28.50M -$8.94M -$5.38M -$2.06M -$762K
Capital Expenditure -$1.04M -- -- -- -- -- -- -- --
Free Cash Flow -$23.62M -- -- -- -- -- -- -- --
Investing Cash Flow -$1.04M -- -- -- -$15.00M -- -- -- -$100K
Common Stock Issued $27.54M $27.79M $775K $699K $80.25M $24.91M $12.21M $900K $2.06M
Financing Cash Flow $27.61M $18.21M -$4.22M $729K $96.36M $23.89M $12.21M $900K $2.06M
Net Change in Cash $3.83M -$14.93M -$16.30M -$22.66M $52.84M $14.97M $6.81M -$1.18M $1.23M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$4.72M -$1.27M -$5.41M -$5.26M -$6.47M -$24.46M -$9.74M -$9.22M
Depreciation & Amortization $100K $100K $52K -- -- -- -- --
Stock-Based Compensation $1.12M $1.36M $1.50M $3.32M $2.98M $1.53M $2.08M $1.76M
Change in Receivables $3.20M -$3.93M $3.81M -$2.58M -$99K -$322K -$102K -$72K
Operating Cash Flow -$3.39M -$3.17M -$3.40M -$2.94M -$5.44M -$7.38M -$6.82M -$11.01M
Common Stock Issued -- -- -- $0 $0 $22.27M $5.27M --
Financing Cash Flow -- -- -- $67K $0 $22.27M $5.27M -$2.08M
Net Change in Cash -$2.08M -$2.95M -$3.39M -$2.98M -$5.64M $14.04M -$1.58M -$12.63M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -94766.0% -304535.7% -19187.7% -6938.8% -16106.6% -111163.6% -- -- --
Net Profit Margin -91866.0% -300585.7% -19360.0% -7299.2% -16762.4% -109990.9% -- -- --
Return on Equity (ROE) -195.3% -131.1% -80.4% -45.4% -37.8% -31.2% -32.5% -75.2% -4.6%
Return on Assets (ROA) -142.0% -106.4% -52.6% -33.4% -30.4% -29.8% -31.4% -71.6% -4.5%
Current Ratio 3.55x 3.14x 2.16x 5.92x 18.95x 13.51x 11.09x 1.03x --
Quick Ratio 3.45x 3.06x 2.04x 4.78x 17.16x 12.37x 9.99x 0.23x --
Debt to Equity 0.04x 0.48x 0.28x 0.25x 0.19x 0.00x 0.01x -- --
Revenue Growth (YoY) +257.1% -91.0% -58.6% +106.6% +1545.5% -- -- -- --
5Y Revenue / Share Growth +120.1% -- -- -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -- -- -- -94766.0% -102752.0% -112458.0% -83046.0% -304535.7%
Net Profit Margin -- -- -- -91866.0% -99774.0% -111016.0% -81592.0% -300585.7%
Return on Equity (ROE) -92.2% -90.4% -212.0% -195.3% -196.6% -192.3% -137.5% -131.1%
Return on Assets (ROA) -77.5% -68.6% -161.1% -142.0% -149.6% -147.3% -107.9% -106.4%
Current Ratio 6.41x 4.04x 4.24x 3.55x 4.17x 4.20x 2.64x 3.14x
Quick Ratio -- -- -- 3.45x 4.00x 4.07x 2.60x 3.06x
Debt to Equity 0.07x 0.07x 0.08x 0.04x 0.04x 0.54x 0.52x 0.48x
Revenue Growth (YoY) -- -- -- -- -- -- +257.1% -100.0%
Source: SEC EDGAR CompanyFacts (CIK 0001711754) · from December 31, 2017 Data through September 30, 2026 · synced Nov 21, 2026, 05:01 UTC · Open in terminal